Joshua Nealon is responsible for public health and medical aspects of COVID-19 and pre-licensure influenza vaccines for Sanofi Vaccines. He has spent a total of 10 years at the company having previously led Medical Evidence Generation activities for influenza vaccines, working as an epidemiologist to support dengue vaccine launch in 2015, and on other vaccine-preventable diseases. He has recently re-joined the company from an epidemiology/biostatistics research and teaching position at the University of Hong Kong where he was focused on vaccine effectiveness and the epidemiology of COVID-19 during the pandemic.

Joshua joined Sanofi from the World Health Organization where he worked as a Technical Officer in vector-borne disease control in Cambodia, Philippines and across the Western Pacific Region, and he has experience in a Hong Kong-based biotech start-up focusing on PCR-based diagnostics and RNA-based therapies. Joshua holds a B.Sc. in Medical Microbiology, an M.Sc. from the London School of Hygiene and Tropical Medicine and his Ph.D. from the University of Edinburgh.